Cargando…

Eubicarbonatemic Hydrogen Ion Retention and CKD Progression

Small-scale trials in patients with chronic kidney disease (CKD) 3-5 have shown that hypobicarbonatemic metabolic acidosis promotes progression of CKD. Accordingly, the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline suggests base administration to patients with CKD when serum bicar...

Descripción completa

Detalles Bibliográficos
Autor principal:	Madias, Nicolaos E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350821/ https://www.ncbi.nlm.nih.gov/pubmed/34401727 http://dx.doi.org/10.1016/j.xkme.2021.03.012

Ejemplares similares

Consequences and therapy of the metabolic acidosis of chronic kidney disease
por: Kraut, Jeffrey A., et al.
Publicado: (2010)

Severe symptomatic hyponatremia due to cerebral salt wasting syndrome in a patient with traumatic head injury and Dandy-Walker malformation of the brain
por: Liangos, Orfeas, et al.
Publicado: (2021)

Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression
por: Kida, Yujiro
Publicado: (2020)

Atypical case of AL amyloidosis with urinary erythrocyte casts
por: Liangos, Orfeas, et al.
Publicado: (2015)

CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes
por: Mullins, C. Daniel, et al.
Publicado: (2022)

THE SELECTIVE ABSORPTION OF POTASSIUM BY ANIMAL CELLS : III. THE EFFECT OF HYDROGEN ION CONCENTRATION UPON THE RETENTION OF POTASSIUM.
por: Stanton, Ralph E.
Publicado: (1923)

Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis
por: Sewaralthahab, Kamal, et al.
Publicado: (2014)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

Optimizing Diet to Slow CKD Progression
por: Molina, Pablo, et al.
Publicado: (2021)

Progression of Medial Arterial Calcification in CKD
por: Manzoor, Shumila, et al.
Publicado: (2018)

A predictive model for progression of CKD
por: Chang, Hsueh-Lu, et al.
Publicado: (2019)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

The Role of Inflammation in CKD
por: Kadatane, Saurav Prashant, et al.
Publicado: (2023)

Chapter 3: Management of progression and complications of CKD
Publicado: (2013)

Self-reported Medication Adherence and CKD Progression
por: Cedillo-Couvert, Esteban A., et al.
Publicado: (2018)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Risk Factors and Rate of Progression of CKD in Children
por: Kamath, Nivedita, et al.
Publicado: (2019)

Risk Factors for Progression of CKD with and without Diabetes
por: Zhang, Xiaohong, et al.
Publicado: (2022)

Urinary Metabolite Profile Predicting the Progression of CKD
por: Kim, Yaerim, et al.
Publicado: (2023)

Kidney failure, CKD progression and mortality after nephrectomy
por: Ellis, Robert J., et al.
Publicado: (2022)

Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression
por: Mazzaferro, Sandro, et al.
Publicado: (2021)

Hydrogen Sulfide-to-Thiosulfate Ratio Associated with Blood Pressure Abnormalities in Pediatric CKD
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

Proteomics of CKD progression in the chronic renal insufficiency cohort
por: Dubin, Ruth F., et al.
Publicado: (2023)

Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients
por: Tang, Wei-Hua, et al.
Publicado: (2015)

Preventing CKD in Developed Countries
por: Luyckx, Valerie A., et al.
Publicado: (2019)

Secondary Response to Chronic Respiratory Acidosis in Humans: A Prospective Study
por: González, Silvia B., et al.
Publicado: (2018)

TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in Assessing the Risk of Progression of CKD
por: Nguyen, Ha Hong, et al.
Publicado: (2022)

Chapter 2: Definition, identification, and prediction of CKD progression
Publicado: (2013)

The Balance of the Evidence on Acid-Base Homeostasis and Progression of CKD
por: Scialla, Julia J.
Publicado: (2015)

Lower serum calcium is independently associated with CKD progression
por: Janmaat, Cynthia J., et al.
Publicado: (2018)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Takotsubo Cardiomyopathy: Current Treatment
por: Madias, John E.
Publicado: (2021)

Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis
por: Brightwell, Camille R., et al.
Publicado: (2021)

Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
por: Chase, Herbert S, et al.
Publicado: (2014)

Leukocyte–endothelial interaction in CKD
por: Sarakpi, Tamim, et al.
Publicado: (2023)

Potassium Metabolism and Management in Patients with CKD
por: Yamada, Shinsuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3af08cde1a5o4dho8srhot4squ